Clobenate 0.05% (Cream)
Medicine Details
Category | Details |
---|---|
Generic | Clobetasol propionate |
Company | Jenphar bangladesh ltd |
Also available as |
Indications
- Psoriasis (excluding widespread plaque psoriasis)
- Recalcitrant dermatoses
- Lichen planus
- Discoid lupus erythematosus
- Other skin conditions which do not respond satisfactorily to less potent steroids
Composition
- Clobetasol Propionate Cream: Each gram cream contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Ointment: Each gram ointment contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Scalp Application: Each gram lotion contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Shampoo: Each gram shampoo contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Lotion: Each gram lotion contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
- Clobetasol Propionate Spray: Each gram spray contains Clobetasol Propionate BP 0.5 mg (0.05% w/w)
Pharmacology
Clobetasol Propionate is a very potent topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It inhibits late phase allergic reactions, decreases mast cell density, inhibits cytokine production, and more.
Dosage
- Cream, Ointment: Apply a thin layer to affected skin areas twice daily for adults, elderly, and children over 1 year
- Spray: Apply required quantity once or twice daily to affected areas of the scalp
- Shampoo: Apply to dry scalp once a day to affected areas only, limit to 4 consecutive weeks
- Scalp Solution: Apply required quantity once or twice daily to affected areas of the scalp
Administration
Route of administration: Cutaneous. Creams are especially appropriate for moist or weeping surfaces. Ointments are especially appropriate for dry, lichenified or scaly lesions.
Interaction
Co-administered drugs that can inhibit CYP3A4 have been shown to inhibit the metabolism of corticosteroids leading to increased systemic exposure.
Contraindications
- Rosacea, acne vulgaris, and perioral dermatitis
- Primary cutaneous viral infections
- Hypersensitivity to the preparation
- The use of Clobetasol Propionate skin preparations is not indicated in the treatment of primarily infected skin lesions caused by fungi or bacteria
- Dermatoses in children under one year of age
Side Effects
- Prolonged use can result in systemic absorption
- Local atrophic changes in the skin
- Provocation of the pustular form of psoriasis
- Pigmentation changes and hypertrichosis
Pregnancy & Lactation
Limited data from the use of Clobetasol Propionate cream in pregnant women. Caution should be exercised when administered to a nursing woman.
Precautions & Warnings
- Long-term continuous topical therapy should be avoided especially in infants and children
- Atrophic changes after prolonged treatment with potent topical corticosteroids
Use in Special Populations
In infants and children under 12 years of age, long-term continuous topical corticosteroid therapy should be avoided
Overdose Effects
Acute overdosage is very unlikely to occur
Therapeutic Class
Other Topical corticosteroids
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Do not freeze.